Oncostatin M: A cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells

Journal of Hepatology

Volumn 32, Issue 2, 2000, Pages 218-226

  Levy, Miriam T ^a,d   Trojanowska, Maria ^b   Reuben, Adrian ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Division of Rheumatology and Immunology   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d CENTENARY INSTITUTE   (Australia)

Author keywords

Cirrhosis; Collagen 2(1) promoter; TGF ; Tissue inhibitors of metallo proteinase 1; Transfection

Indexed keywords

COLLAGEN; FIBRONECTIN; MESSENGER RNA; ONCOSTATIN M; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROGENESIS; HUMAN; HUMAN CELL; LIVER CELL; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; STELLATE CELL;

EID: 0033973784     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80066-5     Document Type: Article

References (52)

1. Gressner AM, Bachem MG. Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. [review] Digestion. 56:1995;335-346.
2. Ramadori G. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. [review] Virchows Arch B Cell Pathol. 61:1991;147-158.
3. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. [review] Semin Liver Dis. 10:1990;30-46.
4. Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol. 29:1998;836-847.
5. Gressner AM. Time-related distribution profiles of sulfated glycosaminoglycans in cells, cell surfaces, and media of cultured rat liver fat-storing cells. Proc Soc Exp Biol Med. 196:1991;307-315.
6. Geerts A, Vrijsen R, Rauterberg J, Burt A, Schellinck P, Wisse E. In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol. 9:1989;59-68.
7. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology. 15:1992;234-243.
8. Knittel T, Muller L, Saile B, Ramadori G. Effect of tumour necrosis factor-alpha on proliferation, activation and protein synthesis of rat hepatic stellate cells. J Hepatol. 27:1997;1067-1080.
9. Tiggelman AM, Boers W, Linthorst C, Sala M, Chamuleau RA. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma. J Hepatol. 23:1995;307-317.
10. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA. 83:1986;9739-9743.
11. Ihn H, LeRoy EC, Trojanowska M. Oncostatin M stimulates transcription of the human alpha2(I) collagen gene via the Sp1/Sp3-binding site. J Biol Chem. 272:1997;24666-24672.
12. Gatsios P, Haubeck HD, Van de Leur E, Frisch W, Apte SS, Greiling H, et al. Oncostatin M differentially regulates tissue inhibitors of metalloproteinases TIMP-1 and TIMP-3 gene expression in human synovial lining cells. Eur J Biochem. 241:1996;56-63.
13. Brown TJ, Rowe JM, Liu JW, Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol. 147:1991;2175-2180.
14. Greenwel P, Rojkind M. Accelerated development of liver fibrosis in CCl4-treated rats by the weekly induction of acute phase response episodes: upregulation of alpha1(I) procollagen and tissue inhibitor of metalloproteinase-1 mRNAs. Biochim Biophys Acta. 22:1997;177-184.
15. Iredale JP. Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol. 29:1997;43-54.
16. Malik N, Haugen HS, Modrell B, Shoyab M, Clegg CH. Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol Cell Biol. 15:1995;2349-2358.
17. Hassen M, Kerr C, Langdon C, Richards CD. Overexpression of mouse oncostatin M in joints by adenovirus vector causes pannus like alterations in synovium of mice. Arth Rheum. 41:(suppl):1998;S247.
18. Bamber B, Reife RA, Haugen HS, Clegg CH. Oncostatin M stimulates excessive extracellular matrix accumulation in a transgenic mouse model of connective tissue disease. J Mol Med. 76:1998;61-69.
19. Bruce AG, Linsley PS, Rose TM. Oncostatin M. [review] Prog Growth Factor Res. 4:1992;157-170.
20. Taga T, Kishimoto T. GP130 and the Interleukin-6 family of cytokines. Ann Rev Immunol. 15:1997;797-819.
21. Mosley B, Deimus C, Friend D, Boiani N, Thoma B, Park LS, et al. Dual oncostatin M (Osm) receptors - cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 271:1996;32635-32643.
22. Kuropatwinski KK, De Imus C, Gearing D, Baumann H, Mosley B. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6. J Biol Chem. 272:1997;15135-15144.
23. Chen W-T, Gendrault J, Steffan A, Jeandidier E, Kirn A. Characterization and main properities of cultured fat-storing cells from human and mouse livers; their characterization with viruses. Wisse E, Knook D, Decker K. Cells of The Hepatic Sinusoid. Vol. II. 1989;429-433 Kupffer Cell Foundation, Rijswijk, The Netherlands.
24. Ichiki Y, Smith EA, LeRoy EC, Trojanowska M. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts. J Rheumatol. 24:1997;90-95.
25. Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. [Review] Am J Clin Nutr. 54:(suppl):1991;1135S-1140S.
26. Yamakage A, Kikuchi K, Smith EA, LeRoy EC, Trojanowska M. Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts. J Exp Med. 175:1992;1227-1234.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
28. Ishikawa O, Yamakage A, LeRoy EC, Trojanowska M. Persistent effect of TGF-beta 1 on extracellular matrix gene expression in human dermal fibroblasts. Biochem Biophys Res Commun. 169:1990;232-238.
29. Bishop GA, Rokahr KL, Napoli J, McCaughan GW. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification. Transpl Immunol. 1:1993;253-261.
30. Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z. The synovial expression and serum levels if interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthr Rheum. 40:1997;1096-1105.
31. Nakazato Y, Okada H, Tajima S, Hayashida T, Kanno Y, Suzuki H, et al. Interleukin-4 modulates collagen synthesis by human mesangial cells in a type-specific manner. Am J Physiol. 270:(3 pt 2):1996;F447-F453.
32. Casini A, Pinzani M, Milani S, Grappone C, Galli G, Jezequel AM, et al. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology. 105:1993;245-253.
33. Weiner FR, Giambrone MA, Czaja MJ, Shah A, Annoni G, Takahashi S, et al. Ito-cell gene expression and collagen regulation. Hepatology. 11:1990;111-117.
34. Choe I, Aycock RS, Raghow R, Myers JC, Seyer JM, Kang AH. A hepatic fibrogenic factor stimulates the synthesis of types I, III, and V procollagens in cultured cells. J Biol Chem. 262:1987;5408-5413.
35. Gressner AM, Zerbe O. Kupffer cell-mediated induction of synthesis and secretion of proteoglycans by rat liver fat-storing cells in culture. J Hepatol. 5:1987;299-310.
36. Zerbe O, Gressner AM. Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp Mol Path. 49:1988;87-101.
37. Armendariz-Borunda J, Greenwel P, Rojkind M. Kupffer cells from CCl(4)-treated rat livers induce skin fibroblast and liver fatstoring cell proliferation in culture. Matrix. 9:1989;150-158.
38. Stefanovic B, Hellerbrand C, Holcik M, Briendl M, Liebhaber SA, Brenner DA. Posttranscriptional regulation of collagen alpha-1(I) MRNA in hepatic stellate cells. Mol Cell Biol. 17:1997;5201-5209.
39. Brenner DA, Westwick J, Breindl M. Type I collagen gene regulation and the molecular pathogenesis of cirrhosis. [review] Am J Physiol. 264:1993;G589-G595.
40. Inagaki Y, Truter S, Greenwel P, Rojkind M, Unoura M, Kobayashi K, et al. Regulation of the alpha 2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver. Hepatology. 22:1995;573-579.
41. Iredale JP. Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol. 29:1997;43-54.
42. Richards CD, Kerr C, Tanaka M, Hara T, Miyajima A, Pennica D, et al. Regulation of tissue inhibitor of metalloproteinase-1 in fibroblasts and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1, and IL-6. J Immunol. 159:1997;2431-2437.
43. Iredale JP, Benyon RC, Arthur MJP, Ferris WF, Alcolado R, Winwood PJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 24:1996;176-184.
44. Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, et al. Tissue inhibitor of metalloproteinase-1 and - 2 RNA expression in rat and human liver fibrosis. Am J Pathol. 150:1997;1647-1659.
45. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJP. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology. 110:1996;821-831.
46. George DK, Ramm GA, Powell LW, Fletcher LM, Walker NI, Cowley LL, et al. Evidence for altered hepatic matrix degradation in genetic haemochromatosis. Gut. 42:1998;715-720.
47. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJ. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci. 89:1995;75-81.
48. Romanelli RG, Caligiuri A, Carloni V, Defranco R, Montalto P, Ceni E, et al. Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta (1). Br J Pharm. 122:1997;1047-1054.
49. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology. 24:1996;759-765.
50. Lee FY, Lu RH, Tsai YT, Lin HC, Hou MC, Li CP, et al. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. Scand J Gastroenterol. 31:1996;500-505.
51. Yamashiki M, Kosaka Y, Nishimura A, Watanabe S, Nomoto M, Ichida F. Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults. J Clin Lab Anal. 12:1998;77-82.
52. Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol. 105:1996;254-259.